Michael Berman is a medical device investor/entrepreneur who serves on the boards of 9 emerging medical device companies.

Mr. Berman was a co-founder of Velocimed which was sold to St. Jude Medical in April, 2005 for $82.5M;  Director of Lutonix from 2007 until 2011 when it was sold to CR Bard for $225M, plus $100M upon FDA approval; Co-founder and Chairman of BridgePoint Medical from 2005 till 2012 when it was sold to Boston Scientific;Director of UltraShape inc. from 2005 till 2011 when it was sold to Syneron.

From 1995-2000 Mr. Berman was the President of the Cardiology business of Boston Scientific.

Mr. Berman serves on the board of the following companies:Aetherworks
AngioSlide                              www.angioslide.com
Benechill                                 www.BeneChill.com
CardiosonicClearCut MedicalInspireMD                               http://www.inspire-md.com
InterValve                               http://www.intervalveinc.com/
Rebiotix                                  http://rebiotix.com/PharmaCentra                        www.PharmaCentra.comCornell University, BS, 1979
Cornell University, MBA, 1986